Howard Capital Management Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Howard Capital Management Group's XBI Position: Q3 2025 in Review
Howard Capital Management Group sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2025, closing a stake of 2,640 shares — an estimated $219K sold.
Howard Capital Management Group first reported a position in XBI in Q1 2021 and held it in 18 quarters. The position peaked at $24.5M in Q3 2024. 656 funds tracked by Wall St. Rank hold XBI as of Q3 2025.
- Howard Capital Management Group reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2025 after selling out during the quarter.
- Howard Capital Management Group sold 2,640 State Street SPDR S&P Biotech ETF shares in Q3 2025, an estimated $219K.
- Howard Capital Management Group first reported a position in State Street SPDR S&P Biotech ETF in Q1 2021 and held it in 18 quarters.
- Howard Capital Management Group's State Street SPDR S&P Biotech ETF position peaked at $24.5M in Q3 2024.
- 656 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2025.
Based on Howard Capital Management Group's 13F filing for Q3 2025, filed 16 Oct 2025.